Nuria Navarro Coy

The role of maintenance thalidomide therapy in multiple myeloma: MRC Myeloma IX results and meta-analysis

Gareth J. Morgan, Walter M. Gregory, Faith E. Davies et al. · Blood · 2011 · 329 citations

Medicine, Hematology, Oncology +16

Cyclophosphamide, thalidomide, and dexamethasone (CTD) as initial therapy for patients with multiple myeloma unsuitable for autologous transplantation

Gareth J. Morgan, Faith E. Davies, Walter M. Gregory et al. · Blood · 2011 · 196 citations · Full text

Medicine, Hematology, Oncology +15

Cyclophosphamide, thalidomide, and dexamethasone as induction therapy for newly diagnosed multiple myeloma patients destined for autologous stem-cell transplantation: MRC Myeloma IX randomized trial results

Gareth J. Morgan, Faith E. Davies, Walter M. Gregory et al. · Haematologica · 2011 · 160 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

The TRACTISS Protocol: a randomised double blind placebo controlled clinical TRial of Anti-B-Cell Therapy In patients with primary Sjögren’s Syndrome

Sarah Brown, Nuria Navarro Coy, Costantino Pitzalis et al. · BMC Musculoskeletal Disorders · 2014 · 49 citations · Full text

Medicine, Clinical Sciences, Immunology +14

The Addition of Thalidomide to the Induction Treatment of Newly Presenting Myeloma Patients Increases the CR Rate Which Is Likely to Translate Into Improved PFS and OS.

Gareth J. Morgan, Faith E. Davies, Walter M. Gregory et al. · Blood · 2009 · 32 citations

Medicine, Hematology, Oncology +7